REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
News

New Sheba Study Finds: The Pfizer-BioNTech COVID-19 Vaccine is Safe and Effective for Pregnant Women

Pregnant Women
A second Sheba study that focused on the COVID vaccine during pregnancy, suggests that the vaccination of pregnant women may also protect their newborns ‌against‌ ‌COVID-19.

390 pregnant women who received the Pfizer-BioNTech COVID-19 vaccine participated in a new Sheba study to determine the prevalence of side effects that may harm them or their unborn children. According to the study, only 0.8% of pregnant women suffered from a fever over 39 degrees Celsius, while the incidence of bleeding, rupture of membranes, or precipitous labor as a result of the vaccine was insignificant.

“All of the vaccinated pregnant women responded well to the vaccine and displayed a high level of blood antibodies, which was however somewhat lower compared to vaccinated women who were not pregnant,” said Prof. Yoav Yinon, Head of Fetal Medicine, Obstetrics and Gynecology at Sheba Medical Center and one of the principal investigators of the study.

In a separate study, Sheba researchers observed that among 64 vaccinated and pregnant participants, blood tests indicated that 96% of the fetuses received COVID-19 antibodies from their mothers through the umbilical cord, providing them with a level of protection against the virus.

“Comparing the test results of women who recovered from COVID-19 to the results of women who were inoculated showed that the umbilical cord blood of the latter had a much higher level of antibodies,” said Prof. Yinon, who added: “We still don’t know how long the mother’s vaccination protects her baby after birth, but we can safely estimate that as is the case with other vaccines, the protection will last for at least a few months. Our studies prove the safety and efficacy of inoculating pregnant women for COVID-19, and also the benefit for their newborns.”

Related
new OPMD clinic
New Sheba Oculopharyngeal Muscular Dystrophy Clinic Promises Improved Care
Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic condition causing weakness in the muscles around the upper eyelids and throat. While the mutated gene that…
Read More
CAR T-Cell
CAR T-cell Therapy for Multiple Myeloma at Sheba
CAR T-cell therapy is a revolutionary blood cancer treatment that helps the body combat tumors using its own T-cells. The therapy involves collecting the patient's…
Read More
Darina's Journey
Walking again: Young Darina's Inspiring Journey
On March 30th, Darina was staying at her grandmother’s house with her mother, Natasha, in a small northern Ukrainian town when an explosion suddenly shook…
Read More